Non-A, non-B hepatitis: dead ends or new horizons?
نویسندگان
چکیده
منابع مشابه
Non-A, non-B hepatitis: dead ends or new horizons?
Researchers who work on hepatitis may sometimes think that they have come to a dead end with non-A, non-B hepatitis, but in recent years there has been gradual progress in knowledge about these diseases. A hepatitis A like agent that causes epidemic waterborne non-A, non-B hepatitis has been characterized, and the epidemiology of the different forms of non-A, non-B hepatitis has been clarified....
متن کاملNon-A, non-B hepatitis.
Diagnosis of non-A, non-B hepatitis (NANB) is made after exclusion of other known causes of hepatitis. Parenterally spread non-a, non-B hepatitis (PNANB) and enterally transmitted non-A, non-B hepatitis (ENANB) almost certainly appear to be two different diseases. The definite causative agents have not hitherto been identified. Much of our knowledge of NANB is based on (i) experimental studies ...
متن کاملNon A/non B hepatitis.
The concept that human viral hepatitis was caused by no more than two etiologic agents stemmed from early volunteer studies in which two epidemiologically distinct types of hepatitis were transmitted to humans (1). These experimentally transmitted diseases closely resembled two forms of naturally occurring viral hepatitis that could be distinguished on epidemiologic grounds. One form was highly...
متن کاملnon-A, non-B hepatitis
1 Dodecanissou Street, Athens 12351, Greece. Abstract To assess the safety and possible efficacy of recombinant human interferon alfa-2b in preventing the development of chronic hepatitis, 24 adults (eight men, 16 women) with acute non-A, non-B (NANB) hepatitis were recruited to a pilot study. Half of the cases were parenterally transmitted and half were community acquired. Twelve patients rece...
متن کاملComparing Anti-hepatitis B Antibody Level in Iranian Obese or Overweight with Non-obese Cases
Background: There is a controversy about the relation between anti-hepatitis B (anti-HBs) antibody level and obesity. We designed this study to compare the vaccine efficacy in obese/overweight and non-obese cases. Methods: In this cross-sectional study, 242 obese/overweight and 85 non-obese individuals were participated. Cases were selected from a referral clinic for obesity and a referral hepa...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1987
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.295.6604.946